Literature DB >> 12814631

A high-throughput-compatible assay for determining the activity of fatty acid amide hydrolase.

Sandy J Wilson1, Timothy W Lovenberg, Ann J Barbier.   

Abstract

Fatty acid amide hydrolase (EC 3.5.1.4.) is the enzyme responsible for the rapid degradation of lipid-derived chemical messengers such as anandamide, oleamide, and 2-arachidonoylglycerol. The pharmacological characterization of this enzyme in vivo has been hampered by the lack of selective and bioavailable inhibitors. We have developed a simple, radioactive, high-throughput-compatible assay for this enzyme based on the differential absorption of the substrate and its products to activated charcoal. The assay was validated using known inhibitors. It may be applied for the identification of new inhibitors from a compound library.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12814631     DOI: 10.1016/s0003-2697(03)00217-3

Source DB:  PubMed          Journal:  Anal Biochem        ISSN: 0003-2697            Impact factor:   3.365


  5 in total

1.  Pharmacological characterization of endocannabinoid transport and fatty acid amide hydrolase inhibitors.

Authors:  Amy K Dickason-Chesterfield; Stephanie R Kidd; Steven A Moore; John M Schaus; Bin Liu; George G Nomikos; Christian C Felder
Journal:  Cell Mol Neurobiol       Date:  2006-05-31       Impact factor: 5.046

2.  Development of highly sensitive fluorescent assays for fatty acid amide hydrolase.

Authors:  Huazhang Huang; Kosuke Nishi; Hsing-Ju Tsai; Bruce D Hammock
Journal:  Anal Biochem       Date:  2006-12-20       Impact factor: 3.365

3.  Inhibition of fatty acid amide hydrolase produces analgesia by multiple mechanisms.

Authors:  Leon Chang; Lin Luo; James A Palmer; Steven Sutton; Sandy J Wilson; Ann J Barbier; James Guy Breitenbucher; Sandra R Chaplan; Michael Webb
Journal:  Br J Pharmacol       Date:  2006-05       Impact factor: 8.739

4.  Preclinical Characterization of the FAAH Inhibitor JNJ-42165279.

Authors:  John M Keith; William M Jones; Mark Tichenor; Jing Liu; Mark Seierstad; James A Palmer; Michael Webb; Mark Karbarz; Brian P Scott; Sandy J Wilson; Lin Luo; Michelle L Wennerholm; Leon Chang; Michele Rizzolio; Raymond Rynberg; Sandra R Chaplan; J Guy Breitenbucher
Journal:  ACS Med Chem Lett       Date:  2015-11-02       Impact factor: 4.345

5.  Identification of a high-affinity binding site involved in the transport of endocannabinoids.

Authors:  S A Moore; G G Nomikos; A K Dickason-Chesterfield; D A Schober; J M Schaus; B-P Ying; Y-C Xu; L Phebus; R M A Simmons; D Li; S Iyengar; C C Felder
Journal:  Proc Natl Acad Sci U S A       Date:  2005-11-28       Impact factor: 11.205

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.